Home > News > IBN seeks venture capitalists
May 13th, 2005
IBN seeks venture capitalists
The Institute of Bioengineering and Nanotechnology (IBN) is looking for venture capitalists for a yet-to-be-named company that will deal in molecular diagnostics.
The IBN's executive director Prof Jackie Ying revealed the spin-off at the institute's official opening yesterday — exactly one year after it moved into the Biopolis.
Institute of Bioengineering and Nanotechnology
TARA Biosystems and Harris & Harris Group Form Company to Improve Safety and Efficacy of New Therapies October 22nd, 2014
Arrowhead Issues Open Letter to Shareholders October 9th, 2014
PEN Inc. Announces New Trading Symbol: PENC: Stock Continues Trading on the OTCQB September 3rd, 2014
Aspen Aerogels, Inc. to Present at Barclays CEO Energy-Power Conference August 27th, 2014
Nano Ruffles in Brain Matter: Freiburg researchers decipher the role of nanostructures around brain cells in central nervous system function October 31st, 2014
Gold nanoparticle chains confine light to the nanoscale October 31st, 2014
'Nanomotor lithography' answers call for affordable, simpler device manufacturing October 31st, 2014
Device invented at Johns Hopkins provides up-close look at cancer on the move: Microscopic view of metastasis could give insight about how to keep cancer in check October 31st, 2014